Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
specific1
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Resectable Pancreatic Ductal Adenocarcinoma (PDAC)(1)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Cedars-Sinai CancerLos Angeles, CA | 100.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →